Introduction {#Sec1}
============

Qin \[[@CR1]\] proposed a fast 3-T MRI method to map the volume and *T* ~2~ of cerebrospinal fluid (CSF) in the brain. A striking finding with this method was the observation of a shorter *T* ~2~ in the peripheral CSF compared with the *T* ~2~ of the CSF in the lateral ventricles. Qin suggested that this *T* ~2~ difference is caused by differences in CSF composition between both areas, implying that CSF *T* ~2~ (*T* ~2,CSF~) can be used as a noninvasive biomarker for CSF composition. This would be highly relevant in the light of the recent attention to the clearance of brain waste products, in which CSF is involved \[[@CR2]--[@CR5]\]. A method that can noninvasively assess CSF composition would provide a noninvasive window on the brain clearance system, with great potential for applications in studying diseases related to dementia such as Alzheimer's disease and cerebral small vessel disease. If *T* ~2,CSF~ is indeed useful as a functional marker of the brain clearance system, it could be studied next to other advanced imaging markers of early brain damage such as microbleeds, microinfarcts, and hippocampus subfield volumes and atrophy. As many of these advanced markers are acquired at 7 T \[[@CR6]--[@CR8]\], it is desirable to implement and evaluate CSF *T* ~2~ mapping at 7 T as well.

At 7 T, ***B*** ~1~ inhomogeneity is considerable and may influence the *T* ~2~ mapping results, despite the relative ***B*** ~1~ insensitivity of the used CSF *T* ~2~ mapping method. Even at 3 T, considerable ***B*** ~1~ inhomogeneity in the brain can be observed \[[@CR9]\]. Also, when *T* ~2~ is measured in peripheral CSF, partial volume effects with tissue cannot be avoided. So, we hypothesized that these partial volume effects and ***B*** ~1~ imperfections can explain the previously observed *T* ~2~ differences. De Vis et al. \[[@CR10]\] obtained a rough estimation of the influence of partial volume effects on the estimated *T* ~2,CSF~ by scanning with two different resolutions. The higher resolution resulted in longer *T* ~2~ times, suggesting a role for partial volume effects. Because the influence of ***B*** ~1~ inhomogeneity and partial volume effects is not clear yet, it remains uncertain to what extent *T* ~2,CSF~ can be used to assess the composition of CSF.

In this work we studied the performance of Qin's CSF *T* ~2~ mapping method at 7 T. The specific goals were to investigate the influence of ***B*** ~1~ and ***B*** ~0~ imperfections on the estimated *T* ~2,CSF~, to assess the influence of partial volume effects, and to evaluate to what extent the previously observed difference in *T* ~2,CSF~ between periphery and ventricles can be explained by ***B*** ~1~, ***B*** ~0~, and partial volume effects. ***B*** ~1~ and ***B*** ~0~ sensitivity was investigated with phantom measurements, and by comparison of the method for 7 and 3 T in healthy humans. Partial volume effects were estimated by removal of the influence of partial volume with tissue, through selection of only the last (longest) echo times (TEs). Also, scanning was done at different resolutions.

Materials and methods {#Sec2}
=====================

Sequence {#Sec3}
--------

The CSF *T* ~2~ mapping sequence used in this research is based on *T* ~2~ preparation, and has been described elsewhere \[[@CR1], [@CR10]\]. For this study the method was further extended to improve the fit reliability of the long *T* ~2~ times by implementation of longer refocusing pulse trains, yielding longer TEs. Briefly, the sequence consists of four parts (Fig. [1](#Fig1){ref-type="fig"}). First, a set of four nonselective water suppression enhanced through *T* ~1~ effects (WET) pulses are applied for saturation to prevent slice history effects. These pulses are optimized for saturation of free water (applicable for *T* ~1~ between 3 and 6 s); the pulse angles are 156°, 71°, 109°, and 90° \[[@CR11]\]. Second, a delay time (*T* ~delay~) follows, where *T* ~1~ relaxation occurs, followed by crusher gradients. Third, *T* ~2~ preparation is applied, consisting of a nonselective 90° pulse, a set of 4, 8, 16, or 32 nonselective refocusing pulses (*R*) according to the Malcolm Levitt (MLEV) phase cycling scheme, and a nonselective −90° pulse with a crusher gradient to crush any remaining transverse magnetization \[[@CR12]\]. Each refocusing pulse *R* is a composite pulse, consisting of $\documentclass[12pt]{minimal}
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                \begin{document}$${\bar{\text{R}}}:90_{\text{ -x}}^{ \circ } , \, 180_{\text{ -y}}^{ \circ } , \, 90_{\text{ -x}}^{ \circ }$$\end{document}$). The duration of a single refocusing pulse was 2.6 ms. *T* ~2~ relaxation occurs during TE~T2-prep~, which is determined by the number of refocusing pulses and the spacing between the centers of the refocusing pulses (*τ*). To achieve long TE~T2-prep~ times, *τ* was chosen as 150 ms. This resulted in TE~T2-prep~ durations of 600, 1200, 2400, and 4800 ms. Also, one scan was acquired without any refocusing pulses; this scan was not used in data analysis. The fourth part of the sequence is a single-shot 2D spin echo (SE) echo planar imaging (EPI) readout. During the EPI train, *T* ~2~ decay also occurs; this can, however, be regarded as a constant factor, and was therefore disregarded in the analysis.Fig. 1Cerebrospinal fluid *T* ~2~ mapping pulse sequence. The sequence consists of four parts: water suppression enhanced through T~1~ effects (WET) presaturation, a fixed delay with duration *T* ~delay~, a *T* ~2~ preparation module with Malcolm Levitt (MLEV) phase cycling, and a spin echo echo planar imaging (SE-EPI) image acquisition. T~2~ relaxation occurs during TE~T2-prep~. To perform *T* ~2~ mapping the sequence was repeated, while the number of refocusing pulses (and therefore TE~T2-prep~) was increased for a fixed interpulse delay *τ*. The applied RF pulses are shown on the RF axis, and the applied gradients are shown on the frequency (F), phase (P), and slice (S) encoding axes

Although the refocusing train in the *T* ~2~ preparation is relatively insensitive to ***B*** ~1~ inhomogeneities because of the MLEV phase cycling scheme, the 90° rectangular pulses before and after the train may fail in the case of ***B*** ~1~ deviations. Consequently, we hypothesized that a fraction of the magnetization may be unaffected by the *T* ~2~-preparation module, which could have a relatively large impact on the measured signal in the case of partial volume effects. Also, in the case of imperfect ***B*** ~1~, *T* ~1~-weighted stimulated echoes may influence the *T* ~2~ measurements, although this effect is expected to be relatively small because of the long *T* ~1~ of CSF (4.4 s \[[@CR13]\]). Therefore, *T* ~2~ mapping with a single echo SE-EPI sequence with various TEs was used as a truly ***B*** ~1~-insensitive reference (shown in the electronic supplemental material).

Nonselective pulses were used where possible to minimize motion sensitivity. Consequently, only the excitation pulse of the SE-EPI readout was selective.

Phantom measurements {#Sec4}
--------------------

Phantom measurements were performed to test the ***B*** ~1~ and ***B*** ~0~ sensitivity. The experiments were performed with a 7-T Philips Achieva scanner (Philips Medical Systems, Best, Netherlands) with a 32-channel head coil (Nova Medical, Wilmington, MA, USA), with a tap water phantom at room temperature. The phantom size was 200 × 95 × 20 mm^3^. The phantom was scanned with the same TEs as used for the in vivo experiments. A single slice was acquired with 3 × 3 × 6 mm^3^ resolution, field of view (FOV) of 240 × 96 mm^2^, *T* ~delay~ of 15 s, \[which is more than three times the *T* ~1~ of CSF (4.4 s \[[@CR13]\])\], and sensitivity encoding (SENSE) \[[@CR14]\] (with SENSE factor 1, meaning that the coil sensitivities of the receive coils were used for optimal coil combination without imaging acceleration). A series of *T* ~2~ maps with increasing through-plane ***B*** ~0~ gradients were acquired to study the effect of diffusion for ***B*** ~1~ of 100%. The following through-plane ***B*** ~0~ gradient strengths were applied by addition of this strength to the linear shim term in the user interface: 0, 0.05, 0.1, 0.2, 0.3, and 0.5 mT/m. The phantom appeared sensitive to free induction decay (FID) artifacts, because of the relatively large volume of water and more pronounced ***B*** ~1~ inhomogeneity \[[@CR15]\]. The acquisition with the highest ***B*** ~0~ gradient yielded images free of FID artifacts, which allowed us to study the ***B*** ~1~ dependency of the CSF *T* ~2~ mapping sequence. ***B*** ~0~ and ***B*** ~1~ maps were acquired, with use of identical resolution and FOV as for the *T* ~2~ mapping acquisitions. The ***B*** ~0~ map was obtained with a gradient echo sequence with two different TEs (1.64 and 2.64 ms). The ***B*** ~1~ mapping sequence was based on the actual flip angle method \[[@CR16]\], with first repetition time (TR) of 40 ms, second TR of 160 ms, TE of 0.96 ms, and a flip angle of 50°.

In vivo measurements {#Sec5}
--------------------

In vivo experiments were performed at both 7 and 3 T to test the feasibility of CSF *T* ~2~ mapping at 7 T, to further assess the sensitivity to ***B*** ~1~ inhomogeneities, and to explore the influence of partial volume effects. Seven healthy volunteers (three men, mean age 34 ± 11 years, age range 21--54 years) participated in this study. Informed consent was given by all volunteers in accordance with the requirements of the Institutional Review Board of the University Medical Center Utrecht (Utrecht, Netherlands). All volunteers were scanned with both a 3-T Philips Achieva scanner with an eight-channel head coil (Philips Healthcare, Best, Netherlands) and the 7-T scanner that was also used for the phantom study. The CSF *T* ~2~ mapping scans were acquired in a single coronal slice, planned through both the lateral ventricles and the fourth ventricle (Fig. [2](#Fig2){ref-type="fig"}a). The scanning parameters are summarized in Table [1](#Tab1){ref-type="table"}. The fixed *T* ~delay~ was 15 s, and TR ranged between 20 and 25 s depending on TE~T2-prep~. Other parameters were as follows: SENSE factor 2.3 in the left--right direction and FOV of 240 × 240 mm^2^. Because of the long TR, the specific absorption rate (SAR) remained well within the specific absorption rate limits, also at 7 T. No additional methods were used to correct the scans for eddy currents. The low bandwidth of the scan may cause distortions in areas with poor shimming, such as the nasal cavities. However, shimming was good in the selected coronal slice. Also ***B*** ~0~ and ***B*** ~1~ maps were acquired. Fig. 2**a** Planning of the cerebrospinal fluid (CSF) *T* ~2~ mapping scans, through the lateral ventricles and the fourth ventricle. **b** CSF *T* ~2~ mapping scans at 7 T for increasing echo times (TE~T2-prep~) (0.6, 1.2, 2.4, and 4.8 s), shown with equal intensity scaling. **c** The region of interest masks used: the periphery (PER; white), the lateral ventricles (LAT; yellow), and the fourth ventricle (FOU; red) Table 1Scan parameters used for the in vivo experiments for the cerebrospinal fluid *T* ~2~ mapping sequence (based on *T* ~2~ preparation)Resolution (mm^3^)TE~readout~ (ms)TE~T2-prep~ (ms)EPI factorBandwidth (phase/frequency) (Hz/voxel)Scan duration (min)3 T1 × 1 × 41330--4800^a^1058.1/9612:593 × 3 × 6420--4800^a^6728.2/23082:597 T1 × 1 × 21270--4800^a^1078.4/10823:041 × 1 × 41260--4800^a^1078.4/10823:043 × 3 × 6230--4800^a^3755.1/26423:04*EPI* echo planar imaging, *TE* echo time, *TE* ~T2-prep~ echo time of T~2~-preparation^a^The TE~T2-prep~ values used were 0, 600, 1200, 2400, and 4800 ms.

Data analysis {#Sec6}
-------------

### Phantom {#Sec7}

The resulting *T* ~2~ estimates were analyzed as a function of ***B*** ~1~ and ***B*** ~0~. ***B*** ~1~ sensitivity was assessed with use of the scans with the highest ***B*** ~0~ gradient strength (0.5 mT/m), where no FID artifacts were present. The ***B*** ~1~ range present in the scan was used. On the basis of ***B*** ~1~ in each voxel, the voxels were sorted over eight bins of 5% ***B*** ~1~, leading to ***B*** ~1~ bins ranging from (85 ± 2.5)% to (120 ± 2.5)%. The signal was averaged over each ***B*** ~1~ bin, and *T* ~2~ values were fitted over this averaged signal. ***B*** ~0~ sensitivity was assessed with the various applied ***B*** ~0~ gradient strengths (0, 0.05, 0.1, 0.2, 0.3, and 0.5 mT/m). In each scan, only voxels with ***B*** ~1~ between 97.5% and 102.5% were included. An additional intensity threshold was applied on the scan with the longest TE~T2-prep~ to minimize the influence of artifacts in the lower ***B*** ~0~ gradient scans. This threshold was set at 75% of the maximum intensity for the longest TE. The signal of all voxels included was averaged over each scan, and *T* ~2~ values were fitted over this averaged signal.

### In vivo {#Sec8}

Three regions of interest (ROIs) were defined on the acquired in vivo scans: the lateral ventricles, the fourth ventricle, and peripheral CSF. The ROI masks were made by our applying an intensity threshold to the first TE (TE~T2-prep~ = 0.6 s). The intensity threshold was set at 25% of the maximum intensity in the image. Figure [2](#Fig2){ref-type="fig"}b and c shows the acquired CSF *T* ~2~ mapping scan at 7 T with a resolution of 1 × 1 × 4 mm^3^ at all TEs for one volunteer, and the ROIs used. Conservative ROIs were used in the ventricles by our eroding the intensity-based ROIs with one voxel to minimize both partial volume and motion sensitivity. Erosion of the peripheral ROIs was not feasible.

The signal was averaged over each ROI, and *T* ~2~ values were fitted over this averaged signal, with use of a single exponential decay model. Also mean ***B*** ~0~ and ***B*** ~1~ values were determined for each ROI. To minimize the influence of, for example, motion or partial volume effects on the data analysis, only fit results with *R* ^2^ of 0.99 or higher were considered.

### Partial volume assessment {#Sec9}

In the peripheral CSF an additional assessment of the influence of partial volume was made by our performing a partial volume correction. Only TE~T2-prep~ values of at least 1200 ms (excluding the shortest TE~T2-prep~ of 600 ms) were taken into account in the analysis. Thereby, maximal nulling of, for example, tissue signal was achieved, since the *T* ~2~ values of tissue are below 100 ms \[[@CR17], [@CR18]\], about ten times shorter than the minimal TE~T2-prep~ used. The analysis with only the last TE~T2-prep~ times was also performed on the phantom scans to check for any systematic errors for all ***B*** ~0~ gradient strengths applied and ***B*** ~1~ between 97.5% and 102.5%.

All data analysis was performed in MATLAB (version 2015B, The MathWorks, Natick, MA, USA). IBM SPSS Statistics (version 21.0) was used for statistical analysis. Median *T* ~2,CSF~ values and full ranges are reported. Wilcoxon signed-rank tests (significance level *p* \< 0.05) were used to compare CSF T~2~ values in the lateral and fourth ventricles with those in the periphery to explore the observed *T* ~2~ differences.

Results {#Sec10}
=======

Phantom measurements {#Sec11}
--------------------

Figure [3](#Fig3){ref-type="fig"} shows the results of the phantom measurements for the ***B*** ~1~ dependency (Fig. [3](#Fig3){ref-type="fig"}a) and ***B*** ~0~ gradient dependency (Fig. [3](#Fig3){ref-type="fig"}b). The CSF *T* ~2~ mapping sequence measured a *T* ~2~ of 1.71 s (95% confidence interval 1.66--1.76 s) for ***B*** ~1~ of (100 ± 2.5)% and ***B*** ~0~ gradient strength of 0 mT/m. The sequence showed only minor ***B*** ~1~ sensitivity (assessed in the scans with ***B*** ~0~ gradient strength of 0.5 mT/m), with *T* ~2~ ranging from 1.41 s (95% confidence interval 1.38--1.43 s) at ***B*** ~1~ of (85 ± 2.5)% to 1.49 s (95% confidence interval 1.40--1.57 s) at ***B*** ~1~ of (105 ± 2.5)%. Also minor ***B*** ~0~ gradient dependency was observed.Fig. 3Results of the phantom measurements for the *B* ~1~ (**a**) and ***B*** ~0~ gradient dependency (**b**) showing the fitted *T* ~2~ for different ***B*** ~1~ values and through-plane ***B*** ~0~ gradient strengths, respectively. The error bars show the 95% confidence interval of the fitted *T* ~2~. The cerebrospinal fluid *T* ~2~ mapping sequence shows only minor sensitivity to ***B*** ~1~ and to the through-plane ***B*** ~0~ gradient (and thus to diffusion). The effect of the ***B*** ~0~ gradient was most apparent for the highest ***B*** ~0~ gradient. The ***B*** ~1~ dependency was determined with a ***B*** ~0~ gradient strength of 0.5 mT/m to avoid free induction decay (FID) artifacts in regions with ***B*** ~1~ deviating from 100%. For a ***B*** ~0~ gradient of 0.2 mT/m, the confidence interval was greater because of FID artifacts

In vivo measurements {#Sec12}
--------------------

Thirty-five CSF *T* ~2~ mapping scans were acquired, for both field strengths and the different resolutions. Per scan, three fits were made, one per ROI, resulting in a total of 105 fits (42 at 3 T, 63 at 7 T). On the basis of the strict requirement on minimum *R* ^2^, 14 fits were excluded (four at 3 T, ten at 7 T), which corresponds to 13% of the total number of fits (10% at 3 T, 16% at 7 T); see Table [2](#Tab2){ref-type="table"} for a detailed overview. Table 2Number of scans acquired and *T* ~2~ fits performed, and the number of excluded *T* ~2~ fits per region of interestResolution (mm^3^)ScansFitsExcluded fitsLateral ventriclesFourth ventriclePeriphery3 T 1 × 1 × 4721010 3 × 3 × 6721210 Total14422207 T 1 × 1 × 2721010 1 × 1 × 4721130 3 × 3 × 6721140 Total2163280

The in vivo results for the scans with a resolution of 1 × 1 × 4 mm^3^ are summarized in Fig. [4](#Fig4){ref-type="fig"}. The results for the other resolutions were not significantly different from the data shown here (all data are shown in Tables S3, S4, S5). Although *T* ~2~ differences between the resolutions were not significant, in most cases the shortest *T* ~2~ times were observed for the largest voxel sizes.Fig. 4In vivo results: *T* ~2~ (**a**), ***B*** ~1~ (**b**), and ***B*** ~0~ gradient (**c**) for the three different regions of interest. Outliers are represented by a square. Significant differences in measured *T* ~2~ were found between the periphery and the lateral and fourth ventricles at 3 T (indicated by an asterisk)

At 7 T significantly shorter *T* ~2~ times were found compared with at 3 T. At 3 T the *T* ~2~ times measured in the periphery were significantly shorter than those measured in the lateral and fourth ventricles. The *T* ~2~ times measured at 7 T were not significantly different between the three ROIs. At 3 T the median ***B*** ~1~ in the periphery was 85% (range 79--90%), while in the lateral and fourth ventricles it was 109% (ranges 106--112% and 103--114%). The median ***B*** ~0~ gradient in the periphery was 0.13 mT/m (range 0.07--0.38 mT/m), while in the lateral and fourth ventricles it was 0.02 and 0.03 mT/m, respectively (range 0.02--0.06 mT/m and 0.01--0.03 mT/m, respectively). At 7 T, lower ***B*** ~1~ values were observed in the periphery and the fourth ventricle \[median 86% (range 75--94%) and 93% (range 62--101%), respectively\], and higher ***B*** ~1~ values were observed in the lateral ventricles \[median 111% (range 109--116)\]. Similar ***B*** ~0~ gradients were observed in the three ROIs \[median 0.07 mT/m (range 0.03--0.10 mT/m), 0.06 mT/m (range 0.04--0.08 mT/m), and 0.06 mT/m (range 0.05--0.09 mT/m), for the lateral ventricles, the fourth ventricle, and the periphery, respectively\].

Partial volume assessment {#Sec13}
-------------------------

Figure [5](#Fig5){ref-type="fig"} shows the results for the additional analysis of peripheral CSF to assess the influence of partial volume. The partial volume correction resulted in longer *T* ~2~ times, with a significant increase of 118 ms at both 3 and 7 T. At 7 T the corrected peripheral CSF T~2~ was quite similar to the ventricular *T* ~2~ (1.01 s vs 1.05 s), while at 3 T the mean peripheral T~2~ was still approximately 200 ms shorter than the ventricular *T* ~2~ times \[1.79 s (range 1.49--1.82 s) vs 2.03 s (range 1.73--2.16 s), *p* = 0.02\]. The results for this analysis of the phantom data are shown in Fig. [6](#Fig6){ref-type="fig"}. Both analysis methods (including all TEs or only the longest TEs) resulted in similar *T* ~2~ values, indicating no systematic errors in the additional analysis with only the longest TEs.Fig. 5*T* ~2~ values of peripheral cerebrospinal fluid resulting from the use of only the longest echo times (TEs) compared with the original analysis. Outliers are represented by a square. At both 3 and 7 T an increase in *T* ~2~ can be observed. The asterisk indicates a significant difference with the original analysis (including all TEs) Fig. 6*T* ~2~ values of the phantom, resulting from the use of only the longest echo times (TEs; orange) compared with the original analysis (blue). Both analyses result in similar *T* ~2~ values

Discussion {#Sec14}
==========

In this research we have shown the feasibility of CSF *T* ~2~ mapping at 7 T with a dedicated CSF *T* ~2~ mapping sequence based on *T* ~2~ preparation, which was initially developed at 3 T. We investigated the sensitivity of this sequence for the influence of ***B*** ~1~, diffusion (***B*** ~0~ gradient), and partial volume effects. The sequence appeared to be relatively insensitive to ***B*** ~1~ and ***B*** ~0~ inhomogeneity. Partial volume effects tend to lower the observed *T* ~2~ values at the periphery. *T* ~2,CSF~ was considerably shorter at 7 T than at 3 T in all three ROIs. The peripheral *T* ~2,CSF~ was significantly shorter than the ventricular *T* ~2,CSF~ at 3 T (but not at 7 T).

The peripheral *T* ~2,CSF~ increased considerably on partial volume correction, as obtained from analysis of long TEs (more than ten times the tissue *T* ~2~). The partial volume correction for the SE-EPI sequence, which was used as a relatively ***B*** ~1~-insensitive reference (data shown in the electronic supplementary material), did not significantly increase *T* ~2~ values, although the SE-EPI sequence showed an even larger *T* ~2~ difference between the periphery and ventricles. The ventricular *T* ~2~ values measured with the CSF *T* ~2~ mapping sequence at 3 T match with *T* ~2~ values found in literature \[[@CR1], [@CR10], [@CR19], [@CR20]\]. Given the results from our measurements and analysis, we believe that the observed *T* ~2~ difference between the ventricular and peripheral CSF could be partly due to physiological differences. However, the different results for different sequences and field strengths and the confounding influence of partial volume effects will make it challenging to accurately isolate and quantify any true physiological effect from confounders. This will hamper applications in research focusing on in vivo evaluation of the (regional) composition of CSF.

***B***~1~ and ***B***~0~ dependency {#Sec15}
------------------------------------

In the phantom measurements only minor ***B*** ~1~ dependency was found for the CSF *T* ~2~ mapping sequence, as shown in Fig. [3](#Fig3){ref-type="fig"}a. Also, the measurements with an increasing through-plane ***B*** ~0~ gradient showed only limited ***B*** ~0~ gradient dependency, except for the highest ***B*** ~0~ gradient (0.5 mT/m), as shown in Fig. [3](#Fig3){ref-type="fig"}b. In the in vivo measurements, the ***B*** ~0~ gradient was similar between the periphery and the ventricles at 7 T, and differed by a maximum of 0.38 mT/m (median ***B*** ~0~ gradient was 0.13 mT/m) at 3 T (Fig. [4](#Fig4){ref-type="fig"}c). This difference in ***B*** ~0~ homogeneity between 3 and 7 T is probably due to different shimming techniques: image-based third-order shimming was used at 7 T, and linear shimming was used at 3 T. The low sensitivity to ***B*** ~0~ gradient shows that the *T* ~2~ mapping sequence is relatively insensitive to diffusion. It is not likely that ***B*** ~0~ gradients due to imperfect shimming contributed considerably to the observed difference in *T* ~2~ between periphery and ventricles.

Partial volume effects {#Sec16}
----------------------

The different resolutions used at both field strengths did not yield considerably different *T* ~2~ values (Tables S3, S4, S5), although there is a trend of longer measured ventricular *T* ~2~ times for smaller voxel sizes at 3 T, similarly to what was found by to De Vis et al. \[[@CR10]\]. As the ventricular ROIs were eroded, the voxels at the edges, where more partial volume is expected, were discarded. For the periphery, however, erosion was not feasible because of the thin shape of the ROI. Moreover, the ROI definition was based on an intensity threshold, which depends on the CSF fraction in each voxel. Since the total subarachnoidal CSF volume is quite small, and distributed over a relatively large area \[[@CR21]\], partial volume is probably present in all peripheral ROIs, independently of the voxel sizes used in this work.

The role of partial volume effects regarding the measured peripheral *T* ~2,CSF~ was investigated by use of the longest TEs only (Fig. [5](#Fig5){ref-type="fig"}) to maximally remove the influence of partial volume. It could seem unexpected that the use of the late TEs reveals a considerable partial volume effect, since the first TE~T2-prep~ is already relatively long compared with the tissue *T* ~2~. The *T* ~2~ of gray matter is approximately 90 ms at 3 T \[[@CR18], [@CR22]\] and 55 ms at 7 T \[[@CR18], [@CR23]\], while the first TE was 600 ms. However, it is possible that partial volume occurs with a compartment with a relatively long *T* ~2~ in the cerebral cortex, like arterial blood (*T* ~2~ around 150 ms at 3 T \[[@CR24], [@CR25]\]) or the outer rim of the cortex (unknown but long *T* ~2~, greater than 100 ms, at 7 T \[[@CR26]\]). At the shortest TE~T2prep~ (600 ms), the signal of arterial blood has decayed to 2%. However, in the case of small partial volume fractions of CSF in the periphery, this could still have a considerable influence on the measured *T* ~2~. The outer layer of the cerebral cortex (layer I) may have a long *T* ~2~ because it contains almost no neuronal cell bodies, and many glial cells instead, similarly to gliotic lesions, which also have a long *T* ~2~ \[[@CR26]\].

Peripheral versus ventricular CSF *T*~2~ and field strength dependence {#Sec17}
----------------------------------------------------------------------

De Vis et al. \[[@CR10]\] found a *T* ~2~ difference of 609 ± 133 ms between the periphery and the ventricles at 3 T, and Qin found a *T* ~2~ difference of 420 ± 155 ms at 3 T. Also in this work a shorter *T* ~2,CSF~ was measured in the periphery compared with the ventricles, as shown in Fig. [4](#Fig4){ref-type="fig"}a. This *T* ~2~ difference is larger at 3 T than at 7 T: the *T* ~2~ difference is 365 ms at 3 T and 161 ms at 7 T, which corresponds to differences of 18% and 15% relative to the *T* ~2~ in the lateral ventricles for 3 and 7 T, respectively. Partial volume correction, which led to a peripheral CSF *T* ~2~ increase of 118 ms at both field strengths (Fig. [5](#Fig5){ref-type="fig"}), resulted in remaining *T* ~2~ differences of 247 ms and only 43 ms for 3 and 7 T, respectively. These correspond to a *T* ~2~ difference of 12% and 4% relative to the ventricular CSF *T* ~2~ for 3 and 7 T, respectively. A relatively larger *T* ~2~ difference was found when a SE-EPI sequence was used, and remained largely unchanged after partial volume correction (data shown in the electronic supplementary material).

These results indicate a true *T* ~2~ difference between peripheral and ventricular CSF. A potential physiological explanation for this observed *T* ~2~ difference could be sought in differences in, for example, in the levels of O~2~, protein, and/or glucose, since these substrates are known to decrease *T* ~2~ \[[@CR20], [@CR27]--[@CR29]\]. However, relatively large concentration differences are necessary to bridge the difference between peripheral and ventricular *T* ~2,CSF~. So although differences in CSF composition may partly cause the observed *T* ~2~ difference, it seems unlikely that these are the only contributor.

The shorter in vivo CSF *T* ~2~ at 7 T than at 3 T (Fig. [4](#Fig4){ref-type="fig"}a) is in line with published in vivo measurements by Daoust et al. \[[@CR20]\]. However, Daoust et al. suggested that the *T* ~2~ of CSF is not field strength dependent, but that residual field gradients cause errors in in vivo measurements at higher field strengths. If the *T* ~2~ measurements are strongly dependent on residual gradients, one might expect that the *T* ~2~ difference between periphery and ventricles observed at 3 T is also largely due to residual field gradients, such as ***B*** ~0~ gradients. However, the CSF *T* ~2~ mapping sequence used in our study showed negligible ***B*** ~0~ gradient dependency for the measured *T* ~2~ up to 0.3 mT/m, while the observed ***B*** ~0~ gradients in the brain were between 0.07 and 0.38 mT/m, and on average well below 0.20 mT/m. The limited diffusion sensitivity of the CSF *T* ~2~ mapping sequence is also visible from the results of the long TE analysis on the phantom measurements. The measured *T* ~2~ remained unchanged when only long TEs (with stronger diffusion weighting) were used (see Fig. [6](#Fig6){ref-type="fig"}).

Implications {#Sec18}
------------

Before CSF *T* ~2~ mapping can be used as a parameter to study diseases such as cerebral small vessel disease, several uncertainties need to be resolved. It is not yet clear to what extent the *T* ~2~ difference between ventricular and peripheral CSF reflects physiological differences in CSF composition. The CSF *T* ~2~ mapping sequence shows a much smaller *T* ~2~ difference compared with SE-EPI, while the difference also varies with field strength. Overall, the *T* ~2~ difference between peripheral and ventricular CSF could (partly) be explained by (a combination of) physiological differences. The possibility that the shorter peripheral *T* ~2~ is entirely caused by an artifact, like *B* ~0~ gradients caused by imperfect shimming and/or partial volume effects between tissue, blood, and CSF, seems unlikely.

Care should be taken when one is interpreting *T* ~2~ measurements of CSF, and more work is necessary to find the true explanations for the *T* ~2~ differences between 3 and 7 T and between the peripheral and ventricular CSF at 3 T.

Limitations {#Sec19}
-----------

The major limitation of this work is that it is an observational study, which limits the extent to which underlying mechanisms causing the observations can be identified. Despite our efforts to separate the effects of partial volume and true physiological differences, it remains uncertain to what extent the observed shorter peripheral *T* ~2,CSF~ is due to different CSF compositions.

Furthermore, the statistical power of this study was limited by the low number of volunteers combined with the stringent *R* ^2^ criterion, which resulted in a relatively large dropout of ROIs.

Moreover, only macroscopic ***B*** ~0~ gradients could be determined in the in vivo scans, and the magnitude of microscopic, subvoxel ***B*** ~0~ gradients remains unknown.

Finally, no in vitro CSF sample was used to validate the in vivo measurements. In vitro CSF is prone to changes in, for example, O~2~ content, compared with in vivo CSF, which may induce *T* ~2~ differences between in vitro and in vivo CSF.

Conclusion {#Sec20}
==========

CSF *T* ~2~ mapping with a dedicated sequence is feasible at both 3 and 7 T, and yields shorter CSF *T* ~2~ times at 7 T compared with 3 T. At 3 T, shorter *T* ~2~ times were found for peripheral CSF compared with ventricular CSF; at 7 T this effect was much smaller. Partial volume effects can partly explain this *T* ~2~ difference, but a physiological contribution to the difference in *T* ~2~ between ventricular and peripheral CSF is possible. The different results for different sequences and field strengths, and the confounding influence of partial volume, will make it challenging to accurately isolate and quantify any true physiological effect for applications in research focusing on in vivo evaluation of the (regional) composition of CSF.
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